Sensus Healthcare, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M |
| Cost of revenue | $15.6M | $17.4M | $10.3M | $14.9M | $10.1M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M |
| Selling, general & administrative | $7.9M | $7.1M | $5.2M | — | — |
| Research and development | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M |
| Operating expenses | $22.2M | $16.3M | $14.4M | $14.8M | $12.9M |
| Operating income | -$10.3M | $8.1M | -$382,000 | $14.8M | $4.1M |
| Interest expense | — | $932,000 | $992,000 | $380,000 | $2,000 |
| Pretax income | -$9.6M | $9.0M | $652,000 | $28.0M | $4.1M |
| Income tax expense | -$1.9M | $2.4M | $167,000 | $3.7M | — |
| Net income | -$7.7M | $6.6M | $485,000 | $24.2M | $4.1M |
| Balance Sheet | |||||
| Cash and equivalents | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M |
| Current assets | $45.9M | $56.7M | $49.5M | $53.2M | $31.2M |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M |
| Current liabilities | $4.7M | $5.9M | $4.2M | $7.7M | $6.0M |
| Total liabilities | $4.9M | $6.3M | $4.9M | $8.7M | $6.2M |
| Stockholders' equity | $48.1M | $55.8M | $48.8M | $48.1M | $26.0M |
| Cash Flow Statement | |||||
| Cash from operations | $528,000 | -$831,000 | -$2.1M | -$1.4M | -$286,000 |
| Depreciation and amortization | $386,000 | $239,000 | $200,000 | $315,000 | $613,000 |
| Stock-based compensation | $295,000 | $323,000 | $328,000 | $187,000 | $415,000 |
| Capital expenditure | $196,000 | $276,000 | $229,000 | $159,000 | $128,000 |
| Free cash flow | $332,000 | -$1.1M | -$2.4M | -$1.6M | -$414,000 |
| Share repurchases | $300,000 | — | $27,000 | $3.0M | — |
| Impairments | — | — | — | — | $88,000 |
Shares outstanding 16.5M · Free float 84.0%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.